Pär Svärdson

This profile gathers the share dealings of Pär Svärdson in Apotea AB (publ), where the filings describe the role as chief executive. Over a trading history stretching from 5 December 2024 to 1 June 2026, the count stands at 14 filings.

Both buying and selling appear: 5 purchases worth €3.5M, against 4 sales worth €70.8M. The net balance comes to €67.3M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 4 purchases and no sales.

Half of the purchases are above €92k and half below. Scaled by market value, the purchases weigh a median 0.041% of market cap (sample: 4 purchases). On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 3 June 2026, the filings show an open-market purchase worth €92k in Apotea AB (publ). The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.